Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Benjamin

Showing results (361-370 of 462) with videos related to

Pageof 47
Sort By:
The Pediatric Infectious Disease Journal|April 17, 2013
Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infantsMichael Cohen-Wolkowiez, Mario Sampson, Barry T Bloom, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|July 26, 2024
Epidemiology and outcomes of bacterial meningitis in the neonatal intensive care unitSamia Aleem, Daniel K Benjamin, Charles M Burns, et al.
The Pediatric Infectious Disease Journal|March 30, 2018
A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive CandidiasisDaniel K Benjamin, David A Kaufman, William W Hope, et al.
Clinical Pharmacology and Therapeutics|March 18, 2011
Safety and pharmacokinetics of multiple-dose anidulafungin in infants and neonatesM Cohen-Wolkowiez, D K Benjamin, L Piper, et al.
Early Human Development|June 28, 2022
Exposure-safety relationship for acyclovir in the treatment of neonatal herpes simplex virus diseaseJessica E Ericson, Daniel K Benjamin, Felix Boakye-Agyeman, et al.
Antimicrobial Agents and Chemotherapy|March 12, 2014
Characterization of the population pharmacokinetics of ampicillin in neonates using an opportunistic study designAdriana Tremoulet, Jennifer Le, Brenda Poindexter, et al.
Clinical Pharmacology and Therapeutics|November 6, 2009
Safety and pharmacokinetics of repeat-dose micafungin in young infantsD K Benjamin, P B Smith, A Arrieta, et al.
Clinical Pharmacokinetics|August 27, 2014
First dose in neonates: are juvenile mice, adults and in vitro-in silico data predictive of neonatal pharmacokinetics of fluconazoleWei Zhao, Chantal Le Guellec, Daniel K Benjamin, et al.
American Journal of Perinatology|November 25, 2024
Trends in Gabapentin Use in Neonatal Intensive Care Units from 2005 to 2020Annette G Roberts, Ryan Kilpatrick, Lindsey D Diaz, et al.
Journal of Clinical and Translational Science|June 30, 2021
Response of the trial innovation network to the COVID-19 pandemicRachel G Greenberg, Lori Poole, Daniel E Ford, et al.
Pageof 47

Showing results (361-370 of 462) with videos related to

Sort By:
Pageof 47
The Pediatric Infectious Disease Journal|April 17, 2013
Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infantsMichael Cohen-Wolkowiez, Mario Sampson, Barry T Bloom, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|July 26, 2024
Epidemiology and outcomes of bacterial meningitis in the neonatal intensive care unitSamia Aleem, Daniel K Benjamin, Charles M Burns, et al.
The Pediatric Infectious Disease Journal|March 30, 2018
A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive CandidiasisDaniel K Benjamin, David A Kaufman, William W Hope, et al.
Clinical Pharmacology and Therapeutics|March 18, 2011
Safety and pharmacokinetics of multiple-dose anidulafungin in infants and neonatesM Cohen-Wolkowiez, D K Benjamin, L Piper, et al.
Early Human Development|June 28, 2022
Exposure-safety relationship for acyclovir in the treatment of neonatal herpes simplex virus diseaseJessica E Ericson, Daniel K Benjamin, Felix Boakye-Agyeman, et al.
Antimicrobial Agents and Chemotherapy|March 12, 2014
Characterization of the population pharmacokinetics of ampicillin in neonates using an opportunistic study designAdriana Tremoulet, Jennifer Le, Brenda Poindexter, et al.
Clinical Pharmacology and Therapeutics|November 6, 2009
Safety and pharmacokinetics of repeat-dose micafungin in young infantsD K Benjamin, P B Smith, A Arrieta, et al.
Clinical Pharmacokinetics|August 27, 2014
First dose in neonates: are juvenile mice, adults and in vitro-in silico data predictive of neonatal pharmacokinetics of fluconazoleWei Zhao, Chantal Le Guellec, Daniel K Benjamin, et al.
American Journal of Perinatology|November 25, 2024
Trends in Gabapentin Use in Neonatal Intensive Care Units from 2005 to 2020Annette G Roberts, Ryan Kilpatrick, Lindsey D Diaz, et al.
Journal of Clinical and Translational Science|June 30, 2021
Response of the trial innovation network to the COVID-19 pandemicRachel G Greenberg, Lori Poole, Daniel E Ford, et al.
Pageof 47